FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000665823> ?p ?o ?g. }

• W2000665823 endingPage "63.e3" @default.
• W2000665823 startingPage "57" @default.
• W2000665823 abstract "BackgroundSpecific immunotherapy (SIT) duration for respiratory allergy is currently based on individual decisions.ObjectiveTo evaluate the differences in clinical efficacy of SIT as a result of the duration between the current recommended limits (3-5 years).MethodsA 5-year prospective, controlled clinical trial of SIT blind until the first year and randomization to a 3-year (IT3) or 5-year (IT5) course was conducted. Of the 239 patients with respiratory allergy caused by D pteronyssinus initially included, 142 completed 3 years of SIT with good compliance. Twenty-seven controls were included at the third year. Efficacy of SIT after 3 (T3) and 5 (T5) years was assessed by using clinical scores, visual analog scales (VASs), rhinitis (RQLQ) and asthma (AQLQ) quality of life questionnaires, skin tests, and serum immunoglobulins.ResultsAt T3, significant reductions were observed in rhinitis (44% in IT3 and 50% in IT5; P < .001), asthma (80.9 % in IT3 and 70.9% in IT5; P < .001) scores, VAS (P < .001 in both), RQLQ (P < .001 in both) and AQLQ (P < .001 in both). At T5, the clinical benefit was maintained in both groups, and IT5 patients presented additional decreases (19%; P = .019) in rhinitis scores. At Tf, specific IgG4 measurements were lower in IT3 (P = .03) without detecting differences in IT5. An increase in asthma score of 133% was the only difference observed in controls.ConclusionClinical improvement is obtained with 3 years of D pteronyssinus SIT. Two additional years of SIT add clinical benefit in rhinitis only. Specific immunotherapy (SIT) duration for respiratory allergy is currently based on individual decisions. To evaluate the differences in clinical efficacy of SIT as a result of the duration between the current recommended limits (3-5 years). A 5-year prospective, controlled clinical trial of SIT blind until the first year and randomization to a 3-year (IT3) or 5-year (IT5) course was conducted. Of the 239 patients with respiratory allergy caused by D pteronyssinus initially included, 142 completed 3 years of SIT with good compliance. Twenty-seven controls were included at the third year. Efficacy of SIT after 3 (T3) and 5 (T5) years was assessed by using clinical scores, visual analog scales (VASs), rhinitis (RQLQ) and asthma (AQLQ) quality of life questionnaires, skin tests, and serum immunoglobulins. At T3, significant reductions were observed in rhinitis (44% in IT3 and 50% in IT5; P < .001), asthma (80.9 % in IT3 and 70.9% in IT5; P < .001) scores, VAS (P < .001 in both), RQLQ (P < .001 in both) and AQLQ (P < .001 in both). At T5, the clinical benefit was maintained in both groups, and IT5 patients presented additional decreases (19%; P = .019) in rhinitis scores. At Tf, specific IgG4 measurements were lower in IT3 (P = .03) without detecting differences in IT5. An increase in asthma score of 133% was the only difference observed in controls. Clinical improvement is obtained with 3 years of D pteronyssinus SIT. Two additional years of SIT add clinical benefit in rhinitis only." @default.
• W2000665823 created "2016-06-24" @default.
• W2000665823 creator A5001653481 @default.
• W2000665823 creator A5006440867 @default.
• W2000665823 creator A5013175387 @default.
• W2000665823 creator A5013757723 @default.
• W2000665823 creator A5021766185 @default.
• W2000665823 creator A5030526062 @default.
• W2000665823 date "2011-01-01" @default.
• W2000665823 modified "2023-09-23" @default.
• W2000665823 title "Three years of specific immunotherapy may be sufficient in house dust mite respiratory allergy" @default.
• W2000665823 cites W1495964112 @default.
• W2000665823 cites W1930217380 @default.
• W2000665823 cites W1942126698 @default.
• W2000665823 cites W1970877567 @default.
• W2000665823 cites W1971098378 @default.
• W2000665823 cites W1974574903 @default.
• W2000665823 cites W1989698086 @default.
• W2000665823 cites W1993775186 @default.
• W2000665823 cites W2007422312 @default.
• W2000665823 cites W2010998136 @default.
• W2000665823 cites W2011847100 @default.
• W2000665823 cites W2015313396 @default.
• W2000665823 cites W2045356786 @default.
• W2000665823 cites W2045455478 @default.
• W2000665823 cites W2056171050 @default.
• W2000665823 cites W2063588874 @default.
• W2000665823 cites W2079088504 @default.
• W2000665823 cites W2105665234 @default.
• W2000665823 cites W2114743889 @default.
• W2000665823 cites W2121760095 @default.
• W2000665823 cites W2128140264 @default.
• W2000665823 cites W2132197286 @default.
• W2000665823 cites W2135028171 @default.
• W2000665823 cites W2142388937 @default.
• W2000665823 cites W2151690666 @default.
• W2000665823 cites W2155701010 @default.
• W2000665823 cites W2156787187 @default.
• W2000665823 cites W2312829609 @default.
• W2000665823 cites W2604596332 @default.
• W2000665823 doi "https://doi.org/10.1016/j.jaci.2010.10.025" @default.
• W2000665823 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21211641" @default.
• W2000665823 hasPublicationYear "2011" @default.
• W2000665823 type Work @default.
• W2000665823 sameAs 2000665823 @default.
• W2000665823 citedByCount "71" @default.
• W2000665823 countsByYear W20006658232012 @default.
• W2000665823 countsByYear W20006658232013 @default.
• W2000665823 countsByYear W20006658232014 @default.
• W2000665823 countsByYear W20006658232015 @default.
• W2000665823 countsByYear W20006658232016 @default.
• W2000665823 countsByYear W20006658232017 @default.
• W2000665823 countsByYear W20006658232018 @default.
• W2000665823 countsByYear W20006658232019 @default.
• W2000665823 countsByYear W20006658232020 @default.
• W2000665823 countsByYear W20006658232021 @default.
• W2000665823 countsByYear W20006658232022 @default.
• W2000665823 countsByYear W20006658232023 @default.
• W2000665823 crossrefType "journal-article" @default.
• W2000665823 hasAuthorship W2000665823A5001653481 @default.
• W2000665823 hasAuthorship W2000665823A5006440867 @default.
• W2000665823 hasAuthorship W2000665823A5013175387 @default.
• W2000665823 hasAuthorship W2000665823A5013757723 @default.
• W2000665823 hasAuthorship W2000665823A5021766185 @default.
• W2000665823 hasAuthorship W2000665823A5030526062 @default.
• W2000665823 hasConcept C126322002 @default.
• W2000665823 hasConcept C159110408 @default.
• W2000665823 hasConcept C1862650 @default.
• W2000665823 hasConcept C203014093 @default.
• W2000665823 hasConcept C204243189 @default.
• W2000665823 hasConcept C207480886 @default.
• W2000665823 hasConcept C2776042228 @default.
• W2000665823 hasConcept C2778166374 @default.
• W2000665823 hasConcept C2779951463 @default.
• W2000665823 hasConcept C2780510475 @default.
• W2000665823 hasConcept C534529494 @default.
• W2000665823 hasConcept C535046627 @default.
• W2000665823 hasConcept C71924100 @default.
• W2000665823 hasConceptScore W2000665823C126322002 @default.
• W2000665823 hasConceptScore W2000665823C159110408 @default.
• W2000665823 hasConceptScore W2000665823C1862650 @default.
• W2000665823 hasConceptScore W2000665823C203014093 @default.
• W2000665823 hasConceptScore W2000665823C204243189 @default.
• W2000665823 hasConceptScore W2000665823C207480886 @default.
• W2000665823 hasConceptScore W2000665823C2776042228 @default.
• W2000665823 hasConceptScore W2000665823C2778166374 @default.
• W2000665823 hasConceptScore W2000665823C2779951463 @default.
• W2000665823 hasConceptScore W2000665823C2780510475 @default.
• W2000665823 hasConceptScore W2000665823C534529494 @default.
• W2000665823 hasConceptScore W2000665823C535046627 @default.
• W2000665823 hasConceptScore W2000665823C71924100 @default.
• W2000665823 hasIssue "1" @default.
• W2000665823 hasLocation W20006658231 @default.
• W2000665823 hasLocation W20006658232 @default.
• W2000665823 hasOpenAccess W2000665823 @default.
• W2000665823 hasPrimaryLocation W20006658231 @default.
• W2000665823 hasRelatedWork W1991336296 @default.
• W2000665823 hasRelatedWork W2018065273 @default.

• next